Healthcare provider profile · identity verified

Todd Palmerton, MD

Family Practice · ROANOKE, VA · NPI 1013989847

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	456	128
Amlodipine Besylate	Amlodipine Besylate	316	94
Metformin Hcl Er	Metformin Hcl	260	69
Pravastatin Sodium	Pravastatin Sodium	238	65
Omeprazole	Omeprazole	236	76
Lisinopril	Lisinopril	231	67
Levothyroxine Sodium	Levothyroxine Sodium	208	57
Irbesartan	Irbesartan	183	53
Gabapentin	Gabapentin	181	61
Olmesartan Medoxomil	Olmesartan Medoxomil	176	49
Montelukast Sodium	Montelukast Sodium	168	50
Rosuvastatin Calcium	Rosuvastatin Calcium	162	50
Furosemide	Furosemide	159	49
Metoprolol Succinate	Metoprolol Succinate	147	44
Allopurinol	Allopurinol	142	36
Metoprolol Tartrate	Metoprolol Tartrate	139	35
Simvastatin	Simvastatin	137	37
Losartan Potassium	Losartan Potassium	126	43
Hydrochlorothiazide	Hydrochlorothiazide	112	37
Atenolol	Atenolol	98	27
Glimepiride	Glimepiride	98	28
Sertraline Hcl	Sertraline Hcl	94	21
Ozempic	Semaglutide	93	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	88	25
Meloxicam	Meloxicam	87	40
Pantoprazole Sodium	Pantoprazole Sodium	86	27
Tramadol Hcl	Tramadol Hcl	86	25
Albuterol Sulfate Hfa	Albuterol Sulfate	84	29
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	84	30
Carvedilol	Carvedilol	82	24
Duloxetine Hcl	Duloxetine Hcl	80	29
Tamsulosin Hcl	Tamsulosin Hcl	78	24
Escitalopram Oxalate	Escitalopram Oxalate	76	24
Metformin Hcl	Metformin Hcl	70	23
Trazodone Hcl	Trazodone Hcl	65	21
Clopidogrel	Clopidogrel Bisulfate	63	20
Fluoxetine Hcl	Fluoxetine Hcl	63	17
Eliquis	Apixaban	61	14
Citalopram Hbr	Citalopram Hydrobromide	54	17
Potassium Chloride	Potassium Chloride	52	18
Prednisone	Prednisone	51	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	14
Lorazepam	Lorazepam	49	16
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	49	12
Chlorthalidone	Chlorthalidone	48	16
Clonazepam	Clonazepam	43	suppressed
Klor-Con M20	Potassium Chloride	43	11
Esomeprazole Magnesium	Esomeprazole Magnesium	41	13
Fenofibrate	Fenofibrate Nanocrystallized	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Buspirone Hcl	Buspirone Hcl	38	12
Ezetimibe	Ezetimibe	38	13
Valsartan	Valsartan	38	12
Alendronate Sodium	Alendronate Sodium	36	11
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	36	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Jardiance	Empagliflozin	35	11
Enalapril Maleate	Enalapril Maleate	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	14
Cephalexin	Cephalexin	30	25
Azithromycin	Azithromycin	29	27
Januvia	Sitagliptin Phosphate	29	suppressed
Tresiba Flextouch U-100	Insulin Degludec	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	11
Fluticasone Propionate	Fluticasone Propionate	28	12
Colchicine	Colchicine	27	15
Diltiazem 24hr Er	Diltiazem Hcl	27	suppressed
Levemir Flexpen	Insulin Detemir	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	23
Alprazolam	Alprazolam	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Famotidine	Famotidine	25	11
Lovastatin	Lovastatin	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	12
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Torsemide	Torsemide	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	12
Trulicity	Dulaglutide	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Fluconazole	Fluconazole	21	17
Klor-Con M10	Potassium Chloride	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Glipizide Er	Glipizide	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Tiadylt Er	Diltiazem Hcl	19	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Mounjaro	Tirzepatide	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Nystatin	Nystatin	15	suppressed
Ondansetron Odt	Ondansetron	15	13
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Rybelsus	Semaglutide	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Amoxicillin	Amoxicillin	13	11
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Cefdinir	Cefdinir	11	11
Celecoxib	Celecoxib	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error